Vedere Bio Overview
- Year Founded
-
2019
- Status
-
Acquired/Merged
- Employees
-
20
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$280M
- Investors
-
1
Vedere Bio General Information
Description
Developer of gene therapy products intended to make vision restoration a reality. The company's products aim to restore loss of vision caused due to inherited retinal degeneration, as well as other causes of both genetic and non-genetic vision loss regardless of the stage of the disease, thereby enabling patients to get back their vision.
Contact Information
Corporate Office
- 400 Technology Square
- 10th Floor
- Cambridge, MA 02139
- United States
Corporate Office
- 400 Technology Square
- 10th Floor
- Cambridge, MA 02139
- United States
Vedere Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 01-Sep-2020 | $280M | Completed | Generating Revenue | ||
| 3. Early Stage VC (Series A) | 27-Jun-2019 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2019 | Completed | Startup |
Vedere Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Vedere Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Vedere Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Vedere Bio Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Atlas Venture | Venture Capital | Minority | ||
| Mission BioCapital | Venture Capital | Minority | ||
| Retinal Degeneration Fund | Not-For-Profit Venture Capital | Minority |
Vedere Bio FAQs
-
When was Vedere Bio founded?
Vedere Bio was founded in 2019.
-
Where is Vedere Bio headquartered?
Vedere Bio is headquartered in Cambridge, MA.
-
What is the size of Vedere Bio?
Vedere Bio has 20 total employees.
-
What industry is Vedere Bio in?
Vedere Bio’s primary industry is Biotechnology.
-
Is Vedere Bio a private or public company?
Vedere Bio is a Private company.
-
What is the current valuation of Vedere Bio?
The current valuation of Vedere Bio is .
-
What is Vedere Bio’s current revenue?
The current revenue for Vedere Bio is .
-
How much funding has Vedere Bio raised over time?
Vedere Bio has raised $21M.
-
Who are Vedere Bio’s investors?
Atlas Venture, Mission BioCapital, and Retinal Degeneration Fund have invested in Vedere Bio.
-
When was Vedere Bio acquired?
Vedere Bio was acquired on 01-Sep-2020.
-
Who acquired Vedere Bio?
Vedere Bio was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
